<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Scientific Conclusions Are All About the Data--Choosing a Logistics Provider For Biomaterial Transport Should Be As Well

Mon, Aug 20, 2018

In our previous blog we discussed key considerations in the transport of critical biomaterials such as cell and gene therapies, in vitro fertilization shipments or large laboratory bio-sample moves.  There we focused on challenges of customs processing, regional or country regulatory requirements and carrier choice and their associated processes.  These are all part of critical risk assessment and mitigation strategies.  Just as the development of the ground-breaking therapies are driven by good scientific methodologies, so should the choice temperature-controlled logistics providers be driven by unbiased data. Whether it be a standard integrator, or a specialty courier, being investigated for utilization data should drive the decision making process.

Read More


Tags: Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cold Chain, Clinical Trials Logistics, Global Cold Chain Logistics, alternative to dry ice shipping, stem cell frozen shipping, regenerative therapies, deep frozen shipping, cellular therapies, temperature controlled logistics, cryogenic shipping, cold chain shipping, biologics, transportation

Considerations for Successful Biomaterial Transport into Challenging Countries

Thu, Aug 02, 2018

Successful research, development, manufacturing and commercialization in regenerative medicine is an epic challenge, with potentially a more epic reward of saving lives.

Almost equally challenging is working with partners domestically and around the globe to transport temperature controlled materials back and forth to keep progress moving forward.

It seems straightforward enough -  Call your carrier of choice, provide addresses, contact names, documentation about the biomaterials and when you want it to arrive -  simple, right?

Read More


Tags: Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cold Chain, Clinical Trials Logistics, Global Cold Chain Logistics, alternative to dry ice shipping, stem cell frozen shipping, regenerative therapies, deep frozen shipping, cellular therapies, temperature controlled logistics, cryogenic shipping, cold chain shipping, biologics, transportation

Transporting Life: A Journey of Choice

Fri, Jul 27, 2018

Graduating classes of young professionals all over the world are preparing to meet new challenges set before them as the embark on a journey. The lessons and academic content taught in their respective fields of study still fresh in their minds as they interview for that perfect career. Some of them are hoping to solve age old problems and improve the human condition. The Biology and Life Sciences that they have learned in the classroom is now ready to be put to practical use for a worthy cause – discovery. In this new age of emerging personalized medicine, discovery of new characteristics of living cells is what this generation faces. New opportunities to do research that will be the future of treatments. So how will they transport the needed living cells for their research?

Read More


Tags: Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cold Chain, Clinical Trials Logistics, Global Cold Chain Logistics, alternative to dry ice shipping, stem cell frozen shipping, regenerative therapies, deep frozen shipping, cellular therapies, temperature controlled logistics, cryogenic shipping, cold chain shipping, dry ice

Dry Vapor: The Hero for the Ever-Growing CO2 Shortage

Tue, Jul 10, 2018

A carbon dioxide (CO2) shortage has been looming over the life sciences industry — yet many biopharma and biotech leaders alike have remained silent on this issue which is already shaking up our European counterparts. According to Gasworld, the European CO2 business is experiencing the worst supply situation it has seen in decades — primarily affecting Northern and Continental Europe.

Read More


Tags: Cold Chain, Clinical Trials Logistics, cryogenic frozen, alternative to dry ice shipping, temperature controlled logistics, cryogenic shipping, cold chain shipping

Cryoport is the Complete Logistics Solution for Your Clinical Programs

Thu, Oct 19, 2017

Cryoport is the leader in cryogenic and cold chain logistics solutions for the life sciences industry with their wide variety of Cryoport Express® dry vapor shippers, unparalleled informatics and global logistics expertise. The company has now expanded their profile with the launch of their ‘Cryoport. Certified. Cool.’ C3™ 2-8°C solution, which now gives the company complete capabilities to support the entire logistics continuum for regenerative medicine programs, specifically CAR-T therapies, and other temperature-controlled biologics or clinical materials.  

Read More


Tags: Cold Chain, Clinical Trials Logistics

Cryoport Practices Quality by Design (QbD) Approaches When Developing New Products and Processes

Thu, Apr 13, 2017

Cryoport is the industry’s most trusted provider of cold chain logistics solutions for temperature-sensitive life sciences materials, serving biopharmaceutical, IVF and surrogacy and animal health organizations around the world. The company stands alone and is truly unrivaled due to their continuous improvement of their products and processes by executing advantageous Quality by Design (QbD) practices in support of their logistics solutions.

Read More


Cancer MoonShot 2020 Initiative Spurs Immunotherapy Research and Integrated Logistics Need

Thu, Jan 19, 2017

Providing $6.3 billion in funding for medical innovation to expedite the discovery, development and delivery of new treatments and cures, the 21st Century Cures Act (Cures) received overwhelming Congressional approval and was signed into law in December 2016.

Read More


Cold Chain Solutions for Autologous Cell Therapy Commercialization

Wed, Dec 14, 2016

Biopharmaceuticals are inherently fragile and temperature-sensitive, requiring exacting control of shipping and storage conditions to maintain product efficacy. This is especially critical for autologous therapies, where cold chain management solutions involving suitable packaging, storage and data collection, as well as tightly controlled logistics, are needed. As companies conduct clinical trials for these innovative therapies, it is the right time to begin building a comprehensive, integrated supply chain in anticipation of product commercialization. 

Read More


Using Real-World Data to Reduce Cold Chain Risk

Wed, Nov 09, 2016

When planning your cold chain logistics strategy for temperature-sensitive biologic materials, a key consideration is minimizing risk to the quality of the commodity and its on-time delivery. Today, there are tools available that optimize outcomes by using real-world data to create better predictive models for the delivery of shipments anywhere in the world.

Read More


Providing a Logistics Management Solution for Biologic Commodity Transport

Thu, Oct 13, 2016

Autologous cell and gene therapy processes start and end with the patient, so the transport and storage of these biologic materials pose complex logistical challenges. Depending on the severity of the patient’s illness, there may be limited opportunities for sample collection and, consequently, manufacture of the potential therapy. Furthermore, any variation in temperature or any interruption in the supply chain, can delay delivery and administration of the therapy to the patient. Irregularities in the cold chain may also affect clinical trial results by compromising data integrity as well as product efficacy and safety. To address these challenges, Cryoport and Database Integrations have launched an integrated solution to manage patient and manufacturer scheduling logistics at every stage of the supply chain for both clinical trial and commercialization processes. 

Read More